TY - JOUR
T1 - Kinetic analysis of propranolol‐induced impairment of its own metabolism in rats
AU - KAGIMOTO, NORIKO
AU - MASUBUCHI, YASUHIRO
AU - FUJITA, SHOICHI
AU - NARIMATSU, SHIZUO
AU - SUZUKI, TOKUJI
PY - 1994/6
Y1 - 1994/6
N2 - Abstract— The effect of repetitive oral administration of propranolol (100 mg kg−1 day−1, 5 days) on the kinetics of liver microsomal propranolol metabolism was investigated in the rat. Vmax values of the high‐affinity phase for biphasic kinetics of propranolol 4‐ and 5‐ hydroxylase activities were decreased by propranolol pretreatment, while those of the low‐affinity phase were unchanged. The Vmax value of monophasic 7‐hydroxylase activity was also decreased. On the other hand, the Vmax value of N‐desisopropylase activity in the propranolol‐treated rats was increased more than 2‐fold compared with non‐treated (control) rats, resulting in a change from monophasic in control rats to biphasic kinetics in propranolol‐treated rats. These findings indicate that repetitive administration of propranolol selectively impairs a CYP2D isozyme that is involved in the high‐affinity phases for propranolol ring‐hydroxylations. 1994 Royal Pharmaceutical Society of Great Britain
AB - Abstract— The effect of repetitive oral administration of propranolol (100 mg kg−1 day−1, 5 days) on the kinetics of liver microsomal propranolol metabolism was investigated in the rat. Vmax values of the high‐affinity phase for biphasic kinetics of propranolol 4‐ and 5‐ hydroxylase activities were decreased by propranolol pretreatment, while those of the low‐affinity phase were unchanged. The Vmax value of monophasic 7‐hydroxylase activity was also decreased. On the other hand, the Vmax value of N‐desisopropylase activity in the propranolol‐treated rats was increased more than 2‐fold compared with non‐treated (control) rats, resulting in a change from monophasic in control rats to biphasic kinetics in propranolol‐treated rats. These findings indicate that repetitive administration of propranolol selectively impairs a CYP2D isozyme that is involved in the high‐affinity phases for propranolol ring‐hydroxylations. 1994 Royal Pharmaceutical Society of Great Britain
UR - http://www.scopus.com/inward/record.url?scp=0028245878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028245878&partnerID=8YFLogxK
U2 - 10.1111/j.2042-7158.1994.tb03846.x
DO - 10.1111/j.2042-7158.1994.tb03846.x
M3 - Article
C2 - 7932057
AN - SCOPUS:0028245878
SN - 0022-3573
VL - 46
SP - 528
EP - 530
JO - Journal of Pharmacy and Pharmacology
JF - Journal of Pharmacy and Pharmacology
IS - 6
ER -